IBDEI0ET ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6821,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,6821,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,6821,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,6822,0)
 ;;=A60.04^^30^398^35
 ;;^UTILITY(U,$J,358.3,6822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6822,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,6822,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,6822,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,6823,0)
 ;;=A60.01^^30^398^33
 ;;^UTILITY(U,$J,358.3,6823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6823,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,6823,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,6823,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,6824,0)
 ;;=B00.1^^30^398^34
 ;;^UTILITY(U,$J,358.3,6824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6824,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,6824,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,6824,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,6825,0)
 ;;=B97.89^^30^398^93
 ;;^UTILITY(U,$J,358.3,6825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6825,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,6825,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,6825,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,6826,0)
 ;;=B97.10^^30^398^22
 ;;^UTILITY(U,$J,358.3,6826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6826,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,6826,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,6826,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,6827,0)
 ;;=B34.9^^30^398^94
 ;;^UTILITY(U,$J,358.3,6827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6827,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,6827,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,6827,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,6828,0)
 ;;=A69.20^^30^398^51
 ;;^UTILITY(U,$J,358.3,6828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6828,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,6828,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,6828,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,6829,0)
 ;;=A69.22^^30^398^53
 ;;^UTILITY(U,$J,358.3,6829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6829,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,6829,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,6829,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,6830,0)
 ;;=A69.21^^30^398^52
 ;;^UTILITY(U,$J,358.3,6830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6830,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,6830,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,6830,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,6831,0)
 ;;=A69.29^^30^398^19
 ;;^UTILITY(U,$J,358.3,6831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6831,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,6831,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,6831,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,6832,0)
 ;;=A69.23^^30^398^6
 ;;^UTILITY(U,$J,358.3,6832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6832,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,6832,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,6832,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,6833,0)
 ;;=A51.0^^30^398^30
 ;;^UTILITY(U,$J,358.3,6833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6833,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,6833,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,6833,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,6834,0)
 ;;=A52.3^^30^398^55
 ;;^UTILITY(U,$J,358.3,6834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6834,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,6834,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,6834,2)
 ;;=^5000298
